Garyfallia Papaioannou, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chondrocytes | 7 | 2017 | 803 | 1.380 |
Why?
|
Osteogenesis | 2 | 2016 | 1299 | 0.640 |
Why?
|
Proto-Oncogene Proteins A-raf | 1 | 2017 | 9 | 0.600 |
Why?
|
MicroRNAs | 6 | 2018 | 3731 | 0.580 |
Why?
|
Growth Plate | 3 | 2017 | 274 | 0.560 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 203 | 0.560 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 480 | 0.520 |
Why?
|
Chondrogenesis | 1 | 2017 | 247 | 0.510 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2017 | 489 | 0.510 |
Why?
|
Bone Development | 2 | 2017 | 483 | 0.470 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2015 | 331 | 0.460 |
Why?
|
Mitogens | 1 | 2010 | 232 | 0.370 |
Why?
|
Histone Deacetylases | 1 | 2015 | 729 | 0.370 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1683 | 0.340 |
Why?
|
Osteoblasts | 1 | 2014 | 1163 | 0.330 |
Why?
|
Thyroid Diseases | 2 | 2010 | 378 | 0.310 |
Why?
|
Cyclosporine | 1 | 2010 | 784 | 0.310 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2028 | 0.290 |
Why?
|
Signal Transduction | 4 | 2018 | 23387 | 0.250 |
Why?
|
Stem Cells | 2 | 2016 | 3563 | 0.240 |
Why?
|
Diphosphonates | 3 | 2014 | 625 | 0.240 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3617 | 0.220 |
Why?
|
Lymphocytes | 1 | 2010 | 2614 | 0.210 |
Why?
|
Imidazoles | 3 | 2014 | 1205 | 0.210 |
Why?
|
Helicobacter pylori | 2 | 2019 | 381 | 0.200 |
Why?
|
Helicobacter Infections | 2 | 2019 | 385 | 0.200 |
Why?
|
Bone Density Conservation Agents | 3 | 2014 | 774 | 0.200 |
Why?
|
Osteoporosis, Postmenopausal | 3 | 2014 | 386 | 0.200 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5519 | 0.170 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4147 | 0.150 |
Why?
|
Cartilage, Articular | 2 | 2015 | 1095 | 0.150 |
Why?
|
Limb Deformities, Congenital | 1 | 2018 | 136 | 0.150 |
Why?
|
Osteoarthritis | 2 | 2015 | 1034 | 0.150 |
Why?
|
raf Kinases | 1 | 2017 | 122 | 0.140 |
Why?
|
Tracheoesophageal Fistula | 1 | 2018 | 129 | 0.140 |
Why?
|
Collagen Type II | 1 | 2016 | 151 | 0.140 |
Why?
|
Eyelids | 1 | 2018 | 263 | 0.140 |
Why?
|
Receptors, Calcitriol | 1 | 2016 | 350 | 0.120 |
Why?
|
Microcephaly | 1 | 2018 | 430 | 0.120 |
Why?
|
Hypertrophy | 1 | 2015 | 568 | 0.110 |
Why?
|
Phosphates | 1 | 2017 | 786 | 0.110 |
Why?
|
Ribonuclease III | 1 | 2015 | 275 | 0.110 |
Why?
|
HMGA2 Protein | 1 | 2013 | 123 | 0.110 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2013 | 101 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2016 | 10472 | 0.110 |
Why?
|
Cell Count | 1 | 2016 | 1831 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.110 |
Why?
|
Wnt Proteins | 1 | 2016 | 721 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1727 | 0.100 |
Why?
|
Organ Size | 1 | 2016 | 2253 | 0.100 |
Why?
|
Osteoporosis | 2 | 2019 | 1581 | 0.100 |
Why?
|
Cell Death | 2 | 2015 | 1695 | 0.100 |
Why?
|
Stromal Cells | 1 | 2016 | 1353 | 0.100 |
Why?
|
Cell Lineage | 2 | 2016 | 2504 | 0.090 |
Why?
|
Mice, Knockout | 5 | 2018 | 14554 | 0.090 |
Why?
|
Oncogenes | 1 | 2016 | 1263 | 0.090 |
Why?
|
Bone Diseases | 1 | 2014 | 416 | 0.090 |
Why?
|
Carcinoma, Papillary | 2 | 2013 | 781 | 0.090 |
Why?
|
Carcinoma, Medullary | 1 | 2010 | 123 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1525 | 0.090 |
Why?
|
Thyrotropin | 2 | 2011 | 850 | 0.090 |
Why?
|
Animals | 9 | 2018 | 168561 | 0.080 |
Why?
|
Calcitonin | 1 | 2010 | 336 | 0.080 |
Why?
|
DNA Primers | 1 | 2013 | 2892 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2006 | 0.080 |
Why?
|
Thyroxine | 3 | 2011 | 666 | 0.080 |
Why?
|
RNA-Binding Proteins | 2 | 2015 | 1899 | 0.080 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9735 | 0.070 |
Why?
|
Endocrine System Diseases | 1 | 2009 | 248 | 0.070 |
Why?
|
Triiodothyronine | 2 | 2011 | 494 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.070 |
Why?
|
Mice | 5 | 2018 | 81045 | 0.070 |
Why?
|
Thyroid Nodule | 1 | 2013 | 750 | 0.070 |
Why?
|
Bone Remodeling | 1 | 2009 | 575 | 0.070 |
Why?
|
Phosphorylation | 1 | 2017 | 8436 | 0.070 |
Why?
|
Bone and Bones | 1 | 2016 | 2575 | 0.070 |
Why?
|
Wound Healing | 1 | 2016 | 2781 | 0.060 |
Why?
|
Thyroid Neoplasms | 3 | 2013 | 2274 | 0.060 |
Why?
|
Thyroid Gland | 1 | 2011 | 1172 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4211 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2017 | 19223 | 0.060 |
Why?
|
Thyroidectomy | 1 | 2009 | 877 | 0.060 |
Why?
|
Homeostasis | 1 | 2014 | 3335 | 0.060 |
Why?
|
Hypothyroidism | 2 | 2009 | 659 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2723 | 0.050 |
Why?
|
Base Sequence | 1 | 2013 | 12797 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2013 | 10943 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2017 | 21821 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5655 | 0.050 |
Why?
|
Apoptosis | 1 | 2017 | 9715 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2010 | 3465 | 0.040 |
Why?
|
Gene Deletion | 2 | 2016 | 2751 | 0.040 |
Why?
|
Hysterectomy | 1 | 2003 | 927 | 0.040 |
Why?
|
Granulation Tissue | 1 | 2016 | 93 | 0.040 |
Why?
|
Transcription Factors | 1 | 2016 | 12164 | 0.040 |
Why?
|
Interleukin-6 | 3 | 2014 | 3199 | 0.030 |
Why?
|
Hydrocortisone | 2 | 2014 | 1825 | 0.030 |
Why?
|
Acute-Phase Reaction | 1 | 2014 | 91 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 644 | 0.030 |
Why?
|
Bone Diseases, Developmental | 1 | 2015 | 130 | 0.030 |
Why?
|
Kyphosis | 1 | 2016 | 233 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 874 | 0.030 |
Why?
|
Resistin | 1 | 2014 | 170 | 0.030 |
Why?
|
Inflammation | 1 | 2013 | 10578 | 0.030 |
Why?
|
Greece | 1 | 2013 | 344 | 0.030 |
Why?
|
Arthritis, Experimental | 1 | 2015 | 291 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1144 | 0.030 |
Why?
|
Triiodothyronine, Reverse | 1 | 2011 | 23 | 0.030 |
Why?
|
Female | 11 | 2018 | 379592 | 0.030 |
Why?
|
Middle Aged | 8 | 2014 | 213127 | 0.020 |
Why?
|
Heterozygote | 1 | 2018 | 2790 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2014 | 4414 | 0.020 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3766 | 0.020 |
Why?
|
Humans | 13 | 2019 | 742088 | 0.020 |
Why?
|
Thyroid Function Tests | 1 | 2011 | 284 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2016 | 2723 | 0.020 |
Why?
|
Tamoxifen | 1 | 2015 | 980 | 0.020 |
Why?
|
Phosphorus | 1 | 2009 | 338 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2016 | 11470 | 0.020 |
Why?
|
Adiponectin | 1 | 2014 | 1099 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 2009 | 339 | 0.020 |
Why?
|
Male | 6 | 2018 | 349538 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2010 | 325 | 0.020 |
Why?
|
Collagen Type I | 1 | 2009 | 592 | 0.020 |
Why?
|
Leptin | 1 | 2014 | 1593 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3612 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10372 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 974 | 0.020 |
Why?
|
Regression Analysis | 1 | 2013 | 6452 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4839 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2009 | 1801 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2010 | 2906 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2009 | 848 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7317 | 0.010 |
Why?
|
Aged | 2 | 2010 | 162944 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5948 | 0.010 |
Why?
|
Thyroid Hormones | 1 | 2003 | 390 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3861 | 0.010 |
Why?
|
Adult | 2 | 2013 | 213712 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 12071 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6608 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10392 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18006 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 72145 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4392 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5753 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11001 | 0.010 |
Why?
|
Time Factors | 2 | 2009 | 40054 | 0.010 |
Why?
|
Disease Progression | 1 | 2010 | 13256 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2013 | 77098 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 24913 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 62966 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 5724 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29010 | 0.010 |
Why?
|
Prospective Studies | 1 | 2011 | 53187 | 0.000 |
Why?
|
Obesity | 1 | 2009 | 12705 | 0.000 |
Why?
|